140 related articles for article (PubMed ID: 22371331)
1. Glutathione peroxidase tagSNPs: associations with rectal cancer but not with colon cancer.
Haug U; Poole EM; Xiao L; Curtin K; Duggan D; Hsu L; Makar KW; Peters U; Kulmacz RJ; Potter JD; Koepl L; Caan BJ; Slattery ML; Ulrich CM
Genes Chromosomes Cancer; 2012 Jun; 51(6):598-605. PubMed ID: 22371331
[TBL] [Abstract][Full Text] [Related]
2. Associations between genetic variation in RUNX1, RUNX2, RUNX3, MAPK1 and eIF4E and riskof colon and rectal cancer: additional support for a TGF-β-signaling pathway.
Slattery ML; Lundgreen A; Herrick JS; Caan BJ; Potter JD; Wolff RK
Carcinogenesis; 2011 Mar; 32(3):318-26. PubMed ID: 21088106
[TBL] [Abstract][Full Text] [Related]
3. Phospholipase A2G1B polymorphisms and risk of colorectal neoplasia.
Abbenhardt C; Poole EM; Kulmacz RJ; Xiao L; Curtin K; Galbraith RL; Duggan D; Hsu L; Makar KW; Caan BJ; Koepl L; Owen RW; Scherer D; Carlson CS; ; Potter JD; Slattery ML; Ulrich CM
Int J Mol Epidemiol Genet; 2013; 4(3):140-9. PubMed ID: 24046806
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1.
Slattery ML; Herrick JS; Lundgreen A; Fitzpatrick FA; Curtin K; Wolff RK
Carcinogenesis; 2010 Sep; 31(9):1604-11. PubMed ID: 20622004
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation in the TGF-β signaling pathway and colon and rectal cancer risk.
Slattery ML; Herrick JS; Lundgreen A; Wolff RK
Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):57-69. PubMed ID: 21068203
[TBL] [Abstract][Full Text] [Related]
6. Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma.
Peters U; Chatterjee N; Hayes RB; Schoen RE; Wang Y; Chanock SJ; Foster CB
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1144-54. PubMed ID: 18483336
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor genes and their association with colon and rectal cancer development and prognosis.
Slattery ML; Herrick JS; Bondurant KL; Wolff RK
Int J Cancer; 2012 Jun; 130(12):2974-80. PubMed ID: 21792899
[TBL] [Abstract][Full Text] [Related]
8. COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations.
Makar KW; Poole EM; Resler AJ; Seufert B; Curtin K; Kleinstein SE; Duggan D; Kulmacz RJ; Hsu L; Whitton J; Carlson CS; Rimorin CF; Caan BJ; Baron JA; Potter JD; Slattery ML; Ulrich CM
Cancer Causes Control; 2013 Dec; 24(12):2059-75. PubMed ID: 24022467
[TBL] [Abstract][Full Text] [Related]
9. Genetic variability in IL23R and risk of colorectal adenoma and colorectal cancer.
Poole EM; Curtin K; Hsu L; Duggan DJ; Makar KW; Xiao L; Carlson CS; Caan BJ; Potter JD; Slattery ML; Ulrich CM
Cancer Epidemiol; 2012 Apr; 36(2):e104-10. PubMed ID: 22154103
[TBL] [Abstract][Full Text] [Related]
10. Variation in selenoenzyme genes and prostate cancer risk and survival.
Geybels MS; Hutter CM; Kwon EM; Ostrander EA; Fu R; Feng Z; Stanford JL; Peters U
Prostate; 2013 May; 73(7):734-42. PubMed ID: 23143801
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation in bone morphogenetic protein and colon and rectal cancer.
Slattery ML; Lundgreen A; Herrick JS; Kadlubar S; Caan BJ; Potter JD; Wolff RK
Int J Cancer; 2012 Feb; 130(3):653-64. PubMed ID: 21387313
[TBL] [Abstract][Full Text] [Related]
12. [Associations between genetic polymorphisms of glutathione S-transferase M1 and T1, smoking and susceptibility to colorectal cancer: a case-control study].
Chen K; Jiang QT; Ma XY; Yao KY; Leng SG; Yu WP; Zhou HG
Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):645-8. PubMed ID: 15777499
[TBL] [Abstract][Full Text] [Related]
13. PPARgamma and colon and rectal cancer: associations with specific tumor mutations, aspirin, ibuprofen and insulin-related genes (United States).
Slattery ML; Curtin K; Wolff R; Ma KN; Sweeney C; Murtaugh M; Potter JD; Levin TR; Samowitz W
Cancer Causes Control; 2006 Apr; 17(3):239-49. PubMed ID: 16489531
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous genotyping of 11 non-synonymous SNPs in the 4 glutathione peroxidase genes using the multiplex single base extension method.
Iida R; Tsubota E; Yuasa I; Takeshita H; Yasuda T
Clin Chim Acta; 2009 Apr; 402(1-2):79-82. PubMed ID: 19161995
[TBL] [Abstract][Full Text] [Related]
15. Interleukin genes and associations with colon and rectal cancer risk and overall survival.
Bondurant KL; Lundgreen A; Herrick JS; Kadlubar S; Wolff RK; Slattery ML
Int J Cancer; 2013 Feb; 132(4):905-15. PubMed ID: 22674296
[TBL] [Abstract][Full Text] [Related]
16. Genetic variation in selenoprotein genes, lifestyle, and risk of colon and rectal cancer.
Slattery ML; Lundgreen A; Welbourn B; Corcoran C; Wolff RK
PLoS One; 2012; 7(5):e37312. PubMed ID: 22615972
[TBL] [Abstract][Full Text] [Related]
17. Glutathione peroxidase 3 serum levels and GPX3 gene polymorphisms in subjects with metabolic syndrome.
Baez-Duarte BG; Mendoza-Carrera F; García-Zapién A; Flores-Martínez SE; Sánchez-Corona J; Zamora-Ginez I; Torres-Rasgado E; León-Chávez BA; Pérez-Fuentes R;
Arch Med Res; 2014 Jul; 45(5):375-82. PubMed ID: 24819036
[TBL] [Abstract][Full Text] [Related]
18. Variants in the alpha-Methylacyl-CoA racemase gene and the association with advanced distal colorectal adenoma.
Daugherty SE; Platz EA; Shugart YY; Fallin MD; Isaacs WB; Chatterjee N; Welch R; Huang WY; Hayes RB
Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1536-42. PubMed ID: 17684125
[TBL] [Abstract][Full Text] [Related]
19. JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.
Slattery ML; Lundgreen A; Kadlubar SA; Bondurant KL; Wolff RK
Mol Carcinog; 2013 Feb; 52(2):155-66. PubMed ID: 22121102
[TBL] [Abstract][Full Text] [Related]
20. Genetic variation in C-reactive protein in relation to colon and rectal cancer risk and survival.
Slattery ML; Curtin K; Poole EM; Duggan DJ; Samowitz WS; Peters U; Caan BJ; Potter JD; Ulrich CM
Int J Cancer; 2011 Jun; 128(11):2726-34. PubMed ID: 20949557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
